Back to search

University of Birmingham

Project 1: “Towards a prophylactic Epstein Barr Virus (EBV) vaccine to prevent EBV -associated malignancies and infectious mononucleosis” and project 2: “Analysing the transcriptional response to histone deacetylase inhibitors treatment in normal and cancer cell lines”

Abstract

dc:description.abstract

The combined thesis submitted for award of the Master of Research in Molecular and Cellular Biology consists of two projects. The first project with the title “towards a prophylactic Epstein Barr Virus (EBV) vaccine to prevent EBV-associated malignancies and infectious mononucleosis” aim was to investigate T cell responses in healthy EBV-seropositive donors to two EBV structural proteins MCP, encoded by BcLF1, and LTP, encoded by BPLF1. The results of first project showed that EBV proteins MCP and LTP are a good vaccine candidates. The second project with the title “analysing the transcriptional response to histone deacetylase inhibitors treatment in normal and cancer cell lines” aim was to analyse the transcriptional response to histone deacetylase inhibitor valproic acid (VPA) treatment in normal and cancer cell lines. The results of second project showed that VPA is not as toxic to normal cells as other chemotherapeutic agents and is a promising candidate for advanced epigenetic chemotherapy.

Degree

thesis:*
Name dc:type.qualificationname
m_rs
Level dc:type.qualificationlevel
m_rs
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bajt, Teja

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Bajt, Teja. Project 1: “Towards a prophylactic Epstein Barr Virus (EBV) vaccine to prevent EBV -associated malignancies and infectious mononucleosis” and project 2: “Analysing the transcriptional response to histone deacetylase inhibitors treatment in normal and cancer cell lines”. m_rs thesis, University of Birmingham, 2014.